To assess whether methicillin resistance is a microbial characteristic associated with deleterious clinical outcome, we performed a cohort study on 908 consecutive episodes of Staphylococcus aureus bacteremia and a case-control study involving 163 pairs of patients matched for preexisting comorbidities, prognosis of the underlying disease, length of hospitalization, and age. Of 908 bacteremic episodes, 225 (24.8%) were due to methicillin-resistant S. aureus (MRSA). Multivariate analysis did not reveal that methicillin resistance was an independent predictor for mortality when shock, source of bacteremia, presence of an ultimately or rapidly fatal underlying disease, acquisition of the infection in an intensive care unit (ICU), inappropriate empirical therapy, female sex, and age were taken into account. Nonetheless, methicillin resistance was an independent predictor for shock. The case-control study could not confirm that shock was linked to MRSA when prior antimicrobial therapy, inappropriate treatment, ICU residence, and female sex were considered. Our data suggest that cohort studies tend to magnify the relationship of MRSA with clinical markers of microbial pathogenicity and that this effect is a shortcoming of these kind of studies that is caused by inadequate control for underlying diseases.
questioned whether the expense of vigorous infection control policies are worthwhile [15] . However, during the last few years, other studies have suggested that methicillin resistance is independently associated with mortality due to S. aureus infections, particularly bacteremia and pneumonia [16] [17] [18] [19] [20] . Controversy surrounding MRSA virulence compared with that of methicillin-susceptible S. aureus (MSSA) may linger in part because of methodological shortcomings of published investigations. In the present study, a large series of patients with S. aureus bacteremia were analyzed to present additional data about the impact of methicillin resistance on selected aspects of the infectious process and outcome.
Patients and Methods
Setting. The Hospital Clínic in Barcelona, Spain, is a 900-bed university center that provides specialized medical and surgical care and is equipped with an intensive care unit (ICU) and a postsurgical unit. Kidney, liver, heart, and bone marrow transplantations are performed, but the hospital lacks a burn unit.
Microbiological methods. During the 8-year study, blood cultures were processed by an automatic nonradiometric system. Isolates were identified according to standard techniques. Methicillin susceptibility was assessed by determining the MIC (microdilution) according to methodology of the National Committee for Clinical Laboratory Standards [21] .
Patient description. The present study focuses on episodes of significant monomicrobial bacteremia due to S. aureus that were diagnosed from January 1991 to December 1998 at a single center. Patients were consecutively enrolled in the study and prospectively followed up. During the study period, there were 944 episodes of Downloaded from https://academic.oup.com/cid/article-abstract/30/2/368/381524 by guest on 24 January 2019 significant S. aureus bacteremia, of which 908 were monomicrobial. The following data were obtained for all patients: age, sex, preexisting comorbidities, prognosis of the underlying disease, prior antibiotic therapy, prior surgery, current administration of 120 mg of corticosteroids/d, current administration of antineoplastic chemotherapy, source of bacteremia, leukocyte count, ICU admission, origin of the infection (community-or hospital-acquired), length of hospitalization before diagnosis of bacteremia, need for mechanical ventilation, empirical and definitive antibiotic treatment, susceptibility to methicillin of the involved strain, presence of shock, and related mortality. Study design. Two types of studies were performed involving patients with S. aureus bacteremia. The first was a populationbased cohort study that used nonconditional logistic regression methods with shock and death as dependent variables. The second was a case-control study that used conditional logistic regression to check for possible shortcomings of the previous cohort study about the influence of MRSA on shock and outcome.
Definitions of terms. Staphylococcal bacteremia was defined as at least 1 blood culture positive for S. aureus and clinically apparent signs and symptoms of sepsis. Comorbidity was defined as a disease or therapy that could predispose patients to infection, alter defense mechanisms, or cause functional impairment, such as the following: diabetes; liver cirrhosis; renal failure; alcoholism (1100 g of alcohol/d); active neoplastic disease; solid organ or bone marrow transplantation; neutropenia; severe chronic obstructive pulmonary disease; severe cardiac disease with symptomatic heart failure; severe dementia; and administration of immunosuppressive drugs (у20 mg of corticosteroids/d on a regular basis or antineoplastic chemotherapy). HIV infection was considered separately. Prognosis of the underlying disease was classified, according to modification of the criteria of McCabe and Jackson [22] , as rapidly fatal (when death was expected within !3 months), ultimately fatal (when death was expected within a period of 13 months but !5 years), and nonfatal (when life expectancy was у5 years).
Prior antibiotic therapy was defined as use of any antimicrobial agent for у7 days during the month prior to the occurrence of the bacteremic episode. Prior surgery was defined as any procedure requiring at least 3 days of hospitalization within the last month. Bloodstream infections were considered nosocomial when cultures of blood specimens obtained 148 h after admission were positive [23] ; otherwise, the bacteremic episode was considered communityacquired. Antibiotic treatment, either empirical or definitive, was considered appropriate if at least 1 of the antibiotics had in vitro activity against the strain involved and the dose and route of administration were adequate. Shock was defined as a systolic pressure of !90 mm Hg that was unresponsive to fluid treatment or required vasoactive drug therapy [24] . Death was considered related to the bloodstream infection if it occurred before the resolution of symptoms or signs or within 7 days from the onset of S. aureus bacteremia and if there was no other explanation.
Follow-up. Patients were observed from the diagnosis of bacteremia until in-hospital death or discharge.
Statistical analysis. Categorical variables were compared by the x 2 test with Yates' correction or Fisher's exact test when necessary, and continuous variables were compared by the Student's t or Mann-Whitney U test. Variables with a in the univariate P р .2 analysis were further analyzed by use of a stepwise nonconditional (population-based cohort study) or conditional (case-control study) logistic procedure with a limit for entering terms of 0.1. Age and length of hospitalization were introduced as continuous variables in decades and multiples of 10, respectively. For the purpose of analysis, the source of bacteremia was divided into 3 categories: low-risk (related mortality rate, !10%), which were iv catheter, urinary tract, ear-nose-larynx, gynecologic, and several manipulation-related sources (including digestive endoscopy, arterial catheterization, and sclerosis of esophageal varices); intermediate-risk (associated mortality rate, 10%-20%), which were osteoarticular, soft-tissue, and unknown sources; and high-risk sources (mortality rate, 120%), which were endovascular, lower respiratory tract, abdominal sources, and CNS foci.
In the case-control study, each patient with MRSA bacteremia (case patient) was matched with a patient with MSSA bacteremia (control patient) who was selected according to the same main underlying disease, prognosis of the underlying disease, and length of hospitalization from admission to diagnosis of the bloodstream infection (stratified as described elsewhere [7] in 4 categories: !72 h, 3-7 days, 8-28 days, and 128 days). When several control patients matched for all these variables, the 1 with the nearest age to the case patient and, if possible, the same sex was selected. If several control patients had all the characteristics, 1 was selected at random. Control patients were chosen without the knowledge of the patients' conditions with regard to shock and survival. The final logistic models contained those variables selected by the stepwise procedure that improved the log likelihood (log likelihood ratio test; ) of the model previously built according to the P value P ! .05 for entry at each step [25] . In the case-control study, conditional logistic regression was also used to calculate the OR and 95% CI for related mortality and shock after adjusting for the variables selected by the stepwise procedure. All calculations were performed by means of the 2D, 3D, 4F, and LR programs (BMDP/DY-NAMIC Release 7.0; BMDP Statistical Software, Los Angeles).
Results
During the study period, there were 908 episodes of significant monomicrobial bacteremia due to S. aureus, of which 225 (24.8%) were caused by MRSA. The differential characteristics of patients with MRSA bacteremia and those with MSSA bacteremia are shown in table 1. MRSA strains originated more frequently from the lower respiratory tract than did MSSA strains (10.2% vs. 6%, respectively;
), and MSSA strains originated more fre-P = .03 quently from endocarditis than did MRSA strains (11.2% vs.
3.1%, respectively;
). However, when sources of bac-P = .0002 teremia were grouped by risk category, MRSA and MSSA strains were equally distributed among low-, intermediate-, and high-risk sources ( ). In addition, patients with MRSA P = .7 bacteremia were more likely than those with MSSA bacteremia to be older, to have a rapidly or ultimately fatal underlying disease, to receive prior antimicrobial therapy, to acquire the infection in the hospital, to stay longer in the hospital before the development of bacteremia, to acquire the infection in an ICU, to require mechanical ventilation, to have surgical procedures, to receive inappropriate empirical treatment, to develop shock, and to die as a consequence of the infection. In the group of patients with MRSA bacteremia, there was a nonsignificant trend for a higher proportion of women ( ) P = .09 and for a higher number of patients with an underlying disease different than HIV infection ( ). Conversely, patients with P = .07 MSSA bacteremia more frequently had septic metastases ( ) and HIV infection ( ) than did those with P = .015 P = .038 MRSA bacteremia.
Results of univariate and multivariate analyses of the association of possible risk factors with shock and death in the population-based cohort study are shown in tables 2 and 3, respectively. Methicillin resistance was not an independent predictor for mortality when shock, source of bacteremia, prognosis of the underlying disease, sex, age, acquisition of the infection in an ICU, and appropriateness of empirical treatment were considered. However, methicillin resistance was an independent predictor for shock, as were mechanical ventilation, source of the bacteremia, rapidly fatal prognosis of the underlying diseases, prior antibiotic administration, and age.
There were 163 pairs of case and control patients who were matched completely for underlying disease, prognosis for the underlying disease, and hospitalization length. Diseases defining pair matching were as follows: no disease, 19 pairs; heart disease, 16; chronic obstructive pulmonary disease, 7; diabetes mellitus, 18; liver cirrhosis, 18; renal failure, 22; hematologic neoplasia, 19; solid neoplasia, 20; HIV infection, 8; organ transplantation, 5; and other diseases, 11. Prognosis of the underlying disease was nonfatal for 72 pairs, ultimately fatal for 86, and rapidly fatal for 5. Univariate analysis showed that case patients were still more likely than control patients to receive prior antimicrobial therapy, to receive inappropriate empirical treatment, to develop shock, to require mechanical ventilation, to have a low-risk source of bacteremia, and to die as a consequence of the infection (table 4). A nonsignificant trend was also noted among case patients toward overrepresentation of women, ICU residence, and longer hospitalization before diagnosis of bacteremia. However, stepwise conditional logistic regression analysis selected only prior antimicrobial therapy (OR, 6.71; 95% CI, 3.2-14.1), inappropriate therapy (OR, 9.52; 95% CI, 4.29-21.27), ICU admission (OR, 2.34; 95% CI, 1.03-5.29), and female sex (OR, 3.38; 95% CI, 1.31-8.69) as variables independently associated with MRSA bacteremia. When these characteristics were taken into account, the apparent association of shock and mortality with MRSA were no longer significant (shock: OR, 2.19; 95% CI, 0.85-5.6; death: OR, 1.74; 95% CI, 0.79-3.78).
Discussion
It is well known that patients with bloodstream infections due to MRSA are more likely than patients with MSSA bacteremia to have serious underlying diseases, poor clinical prognosis, longer hospitalization, and prior antibiotic therapy [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . All these characteristics together with an increasing frequency of surgical procedures, ICU residence, need for mechanical ventilation, shock, and mortality have been observed also for patients with MRSA bacteremia in the present cohort study. With this patient profile, it may be difficult to attribute a particular virulence to MRSA, defined in terms of morbidity or mortality, since preexisting underlying diseases, source of infection, shock, and appropriateness of antibiotic therapy have an important impact on survival [26] [27] [28] [29] . In fact, the nonconditional logistic regression analysis used in the cohort study did not include methicillin resistance as an independent predictor for mortality when shock, source of bacteremia, prognosis of the underlying disease, sex, age, appropriateness of empirical treatment, and acquisition of bacteremia in an ICU were considered. In the present series, shock and a high-risk source of bacteremia (endovascular, lower respiratory tract, abdominal, or CNS focus) were the variables most strongly associated with death. These findings differ from those of other recent investigations involving patients with staphylococcal bacteremia that used similar multivariate analyses, in which a positive association of MRSA with mortality was found [16, 18] . However, in 1 of these studies [16] , shock was not evaluated as an explanatory variable, and in the other [18] , the inclusion of resistance to methicillin in the final logistic model could be tentatively traced to the fact that shock and inadequate empirical therapy were related to a lesser extent to MRSA.
Other studies, most of which were case-control investigations, have indicated that methicillin resistance does not seem to influence outcome when important confounders are taken into account [7] [8] [9] [10] [11] [12] [13] [14] [15] . However, even though in the present cohort study methicillin resistance was not included in the final model predicting mortality, its apparently clear association with shock could still denote a singular virulence of MRSA. Our data indicate that once shock occurred, the risk of a fatal outcome was high regardless of the infecting strain, but the adjusted OR for shock in patients with MRSA bacteremia was almost 2-fold greater than that for shock in patients with MSSA bacteremia. These findings agree with those of a previous study focusing on ventilator-associated pneumonia due to Staphylococcus, in which the presence of bacteremia and shock was more frequent in patients infected with MRSA [20] .
Cohort studies showing an independent association of methicillin resistance with mortality have been criticized as being prone to overestimation of MRSA virulence because of poor adjustment for underlying diseases or severity of clinical condition [7] . A similar criticism could be raised about the association of MRSA with shock, since it is, like mortality, a complex process highly influenced by variables related to prior clinical condition and hemodynamic status [27] . The need for controlling these important confounders is further highlighted by the failure of several basic studies to find differences among MRSA and MSSA strains with regard to possible virulence markers (such as adherence capacity [30, 31] ; intraleukocytic survival [32, 33] ; and production of hemolysins, enzymes, and toxins [34] [35] [36] [37] ); or outcome of experimentally induced infections [34, 35, 37] . Only 1 study reported that lipase production by MRSA was more frequent than that by control strains [38] .
We included preexisting comorbidities and prognosis of the underlying disease as putative explanatory variables for shock and related mortality in our cohort study. However, pooling together several comorbidities may not be the best way to account for the different risks of infectious complications, including shock. The same can be said about prognosis of the underlying disease that was based on modification of the criteria of McCabe and Jackson [22] , whose classification "ultimately fatal" may be too broad to be meaningful enough in this context. To check for these eventual shortcomings in our cohort series, we performed a case-control study that took advantage of the large number of patients we had the opportunity to investigate.
One hundred sixty-three patients with MRSA bacteremia (case patients) could be matched on an individual basis with patients with MSSA bacteremia (control patients) who had the same kind of preexisting comorbidities, prognosis of the underlying disease, and length of hospitalization before diagnosis of the septic episode. After matching, case patients were still more likely than control patients to have prior antimicrobial therapy, to receive inappropriate empirical treatment, to develop shock, to require mechanical ventilation, to be female, to acquire the infection in an ICU, to stay longer in the hospital, and to die as a consequence of the infection. However, when shock and death were included in a conditional logistic regression model after controlling for variables selected by the stepwise procedure as independently associated with case patients (prior antimicrobial therapy, inappropriate empirical therapy, sex, and acquisition of bacteremia in an ICU), mortality and shock were no longer significantly linked to MRSA. We believe that the only real particularity of our case-control study was the strict adjustment for underlying diseases, since prognosis of the underlying disease and length of hospitalization had a good possibility of being influential in the multivariate analysis of the cohort study.
In summary, the present data suggest that cohort studies tend to magnify the relationship of MRSA with clinical markers of microbial pathogenicity and that this effect stems from inadequate control for underlying diseases. If MRSA has any particular tendency to induce shock compared with MSSA, it appears that this tendency is, at most, marginal.
